These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 9479407

  • 1. Nonprescription H2-receptor antagonists.
    Marsh TD.
    J Am Pharm Assoc (Wash); 1997; NS37(5):552-6. PubMed ID: 9479407
    [Abstract] [Full Text] [Related]

  • 2. Switching the histamine H2 receptor antagonist famotidine to nonprescription status in Canada. An economic evaluation.
    Tasch RF, Goeree R, Henke CJ, O'Brien BJ.
    Pharmacoeconomics; 1996 Jan; 9(1):61-75. PubMed ID: 10160088
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Policy analysis of the conversion of histamine2 antagonists to over-the-counter use.
    Kalish SC, Bohn RL, Avorn J.
    Med Care; 1997 Jan; 35(1):32-48. PubMed ID: 8998201
    [Abstract] [Full Text] [Related]

  • 5. Partnership in optimizing management of reflux symptoms: a treatment algorithm for over-the-counter proton-pump inhibitors.
    Boardman HF, Delaney BC, Haag S.
    Curr Med Res Opin; 2015 Jan; 31(7):1309-18. PubMed ID: 25950642
    [Abstract] [Full Text] [Related]

  • 6. Consumer usage patterns of nonprescription histamine2-receptor antagonists.
    Shi CW, Gralnek IM, Dulai GS, Towfigh A, Asch S.
    Am J Gastroenterol; 2004 Apr; 99(4):606-10. PubMed ID: 15089889
    [Abstract] [Full Text] [Related]

  • 7. The risks and benefits of an Rx-to-OTC switch. The case of over-the-counter H2-blockers.
    Oster G, Huse DM, Delea TE, Colditz GA, Richter JM.
    Med Care; 1990 Sep; 28(9):834-52. PubMed ID: 1976142
    [Abstract] [Full Text] [Related]

  • 8. Treatment of gastroesophageal reflux disease.
    Pettit M.
    Pharm World Sci; 2005 Dec; 27(6):432-5. PubMed ID: 16341949
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Over-the-counter histamine2-blocker therapy.
    Gonzalez ER, Grillo JA.
    Ann Pharmacother; 1994 Mar; 28(3):392-5. PubMed ID: 7910767
    [Abstract] [Full Text] [Related]

  • 11. Over-the-counter H2-receptor antagonists for heartburn.
    Med Lett Drugs Ther; 1995 Oct 27; 37(960):95-6. PubMed ID: 7565298
    [No Abstract] [Full Text] [Related]

  • 12. Self-reported effectiveness and physician consultation rate in users of over-the-counter histamine-2 receptor antagonists.
    Shaw MJ, Fendrick AM, Kane RL, Adlis SA, Talley NJ.
    Am J Gastroenterol; 2001 Mar 27; 96(3):673-6. PubMed ID: 11280532
    [Abstract] [Full Text] [Related]

  • 13. Habit, prejudice, power and politics: issues in the conversion of H2-receptor antagonists to over-the-counter use.
    Hunt RH.
    CMAJ; 1996 Jan 01; 154(1):49-53. PubMed ID: 8542566
    [Abstract] [Full Text] [Related]

  • 14. Gastroesophageal reflux in pregnancy: a systematic review on the benefit of raft forming agents.
    Quartarone G.
    Minerva Ginecol; 2013 Oct 01; 65(5):541-9. PubMed ID: 24096290
    [Abstract] [Full Text] [Related]

  • 15. Over the counter H2 receptor antagonists. Serve only as expensive antacids.
    Douds AC, Maxwell JD.
    BMJ; 1994 Oct 29; 309(6962):1156. PubMed ID: 7987114
    [No Abstract] [Full Text] [Related]

  • 16. Drug utilization evaluation of nonprescription H2-receptor antagonists and alginate-containing preparations for dyspepsia.
    Krska J, John DN, Hansford D, Kennedy EJ.
    Br J Clin Pharmacol; 2000 Apr 29; 49(4):363-8. PubMed ID: 10759692
    [Abstract] [Full Text] [Related]

  • 17. Evidence-based treatment of frequent heartburn: the benefits and limitations of over-the-counter medications.
    McRorie JW, Gibb RD, Miner PB.
    J Am Assoc Nurse Pract; 2014 Jun 29; 26(6):330-9. PubMed ID: 24825071
    [Abstract] [Full Text] [Related]

  • 18. Heartburn-dominant, uninvestigated dyspepsia: a comparison of 'PPI-start' and 'H2-RA-start' management strategies in primary care--the CADET-HR Study.
    Armstrong D, Veldhuyzen van Zanten SJ, Barkun AN, Chiba N, Thomson AB, Smyth S, Sinclair P, Chakraborty B, White RJ, CADET-HR Study Group.
    Aliment Pharmacol Ther; 2005 May 15; 21(10):1189-202. PubMed ID: 15882239
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The effect of an Rx-to-OTC switch on medication prescribing patterns and utilization of physician services: the case of H2-receptor antagonists.
    Andrade SE, Gurwitz JH, Fish LS.
    Med Care; 1999 Apr 15; 37(4):424-30. PubMed ID: 10213023
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.